The Epidemiology, Clinical Aspects, Treatment and Preventive Strategies for Infectious Diseases in the Era of Antimicrobial Resistance (AMR)
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 6496
Special Issue Editor
2. County Clinical Emergency Hospital, Sibiu, Romania
Interests: COVID-19; sepsis; clostridioides difficile; respiratory tract infections; bacterial infections; viral infections; arboviral disease; hospital aquired infections; bone and joint infection; surgical site infections
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) is one of the most pressing global health issues of our time, particularly in the context of bacterial and fungal infections. The increasing incidence of multidrug-resistant bacteria and emerging antifungal resistance challenge current diagnostic algorithms, therapeutic strategies, and infection control protocols in both community and healthcare settings.
By 2050, it is projected that antimicrobial resistance (AMR) will have caused an estimated 1.91 million deaths directly attributable to resistant infections, with there being a total of 8.22 million deaths in which AMR played a role. This projected toll highlights the immediate need for intensified efforts to understand, monitor, and combat resistant pathogens.
The clinical burden of drug-resistant infections continues to rise, with pathogens such as Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida species showing alarming levels of resistance to frontline treatments. The convergence of microbial adaptation, antibiotic misuse, and gaps in surveillance has created a complex epidemiological landscape that requires urgent interdisciplinary attention.
This Special Issue, entitled “The Epidemiology, Clinical Aspects, Treatment and Preventive Strategies for Infectious Diseases in the Era of Antimicrobial Resistance (AMR)”, seeks to gather high-quality contributions that explore the biological, clinical, and public health dimensions of AMR in bacterial and fungal pathogens.
We welcome original research articles, reviews, and short communications addressing, but not limited to, the following topics:
- Local, regional, and global epidemiology of multidrug-resistant bacterial and fungal infections;
- Mechanisms of resistance in Gram-positive, Gram-negative, and fungal pathogens;
- Clinical outcomes and management of infections caused by resistant organisms;
- Rapid microbiological diagnostics and antimicrobial susceptibility testing;
- Development of new antimicrobial agents and combination therapies;
- Stewardship programs targeting high-risk settings and vulnerable populations;
- Nosocomial outbreaks and infection prevention strategies;
- Resistance surveillance in humans;
- Biofilm-associated resistance in chronic infections;
- Translational research on host–pathogen interactions in resistant infections.
This Special Issue aims to contribute to a more informed and coordinated global response to AMR by bridging clinical microbiology, infectious diseases, and public health. By fostering collaboration across disciplines, we hope to drive innovation in treatment and prevention, ultimately improving patient outcomes and the sustainability of antimicrobials.
We look forward to your valuable contributions.
Prof. Dr. Victoria Birlutiu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance (AMR)
- multidrug-resistant bacteria
- antifungal resistance
- infectious disease epidemiology
- clinical microbiology
- rapid diagnostics
- biofilm-related infections
- antimicrobial stewardship
- infection prevention
- resistance surveillance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
